XRHealth Acquires PursueCare, Expanding Addiction Care and Payer Reach
XRHealth, a VR therapy telehealth company, acquired virtual addiction care provider PursueCare, its second acquisition since early November following a purchase of Germany-based Living Brain. The deal brings XRHealth ownership of PursueCare's FDA-authorized digital therapeutics, RESET and RESET-O, which support cognitive behavioral therapy and contingency management via smartphone, as well as PursueCare subsidiary Harvest Bio. CEO Eran Orr said PursueCare's acceptance of private insurance, Medicare and Medicaid deepens XRHealth's payer networks, and the combined company has expanded its clinical footprint from 22 to 40 states this year. Financial terms were not disclosed, though public filings show XRHealth issued about $16.25 million in stock to PursueCare and Harvest Bio sellers and separately raised $2.15 million in cash from investors.